ArticleFrontiers in immunology2024

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.